Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 0.01% Atropine for Fast Progressing Myopia
NCT04173780Phase 3Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Feb 2020
- Primary completion
- May 2024
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Strasbourg University Hospital. Started Feb 2020; status: terminated.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT04173780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173780.